Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR)

CompletedOBSERVATIONAL

Enrollment

241

Participants

Timeline

Start Date

January 16, 2019

Primary Completion Date

June 1, 2022

Study Completion Date

February 7, 2024

Conditions

Prostate Cancer

Trial Locations (1)

Thomas Jefferson University, Philadelphia

All Listed Sponsors

lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER

NCT03807492 - Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR) | Biotech Hunter | Biotech Hunter